Replies to post #8311 on BioCurex, Inc.(fka BOCX)

[opportunityknocking]

I hope that 50K was for champagne. This has been the most frustrating 3+ years I have held any stock. This technology holds so much promise and it appears Abbott did not believe it would or could work and apparently neither do investors. We need someone like Carl Icahn to come to the rescue as they did with Imclone. Recaf has the key that fits only the lock to cancer cells. Why aren't we in a deal with every pharmaceutcal company with drugs that target cancer. They can piggyback on Recaf and receive royalties like Microsoft. I am obviously simplifying how the technology works, but as we all know time is of the essence when it comes to any scientific discovery.
I can only assume that we should be seeing the real money as soon as Abbott/GE has done the proper filing for the required permits. This payment (even though it is for a pitiful amount) should at least mean all is well with the technology. Whomever negotiated this should be ashamed. If the royalty had been a million or more Wallstreet would have certainly taken notice. In the real world you must "SHOW ME THE MONEY!" I can at least feel better knowing we are moving forward.